Table 2

Grade 3/4 adverse events in the first cycle of the phase I portion (n = 17)

DHP107 dose levelTotal
150 mg/m2 b.i.d. (n = 3)200 mg/m2 b.i.d. (n = 6)225 mg/m2 b.i.d. (n = 4)250 mg/m2 b.i.d. (n = 4)
Adverse eventsGrade 3Grade 4Grade 3Grade 4Grade 3Grade 4Grade 3Grade 4
Anemia200000114
Neutropenia2021003110
Febrile neutropenia000020103
Hypoalbuminemia000000101
Hypocalcemia000000101
Hypokalemia000000101
Hypophosphatemia000000101
Hypotension000000101
Leukopenia102000317
Worsening anemia000000101
DHP107 dose levelTotal
150 mg/m2 b.i.d. (n = 3)200 mg/m2 b.i.d. (n = 6)225 mg/m2 b.i.d. (n = 4)250 mg/m2 b.i.d. (n = 4)
Adverse eventsGrade 3Grade 4Grade 3Grade 4Grade 3Grade 4Grade 3Grade 4
Anemia200000114
Neutropenia2021003110
Febrile neutropenia000020103
Hypoalbuminemia000000101
Hypocalcemia000000101
Hypokalemia000000101
Hypophosphatemia000000101
Hypotension000000101
Leukopenia102000317
Worsening anemia000000101

Dose‐limiting toxicity.

Table 2

Grade 3/4 adverse events in the first cycle of the phase I portion (n = 17)

DHP107 dose levelTotal
150 mg/m2 b.i.d. (n = 3)200 mg/m2 b.i.d. (n = 6)225 mg/m2 b.i.d. (n = 4)250 mg/m2 b.i.d. (n = 4)
Adverse eventsGrade 3Grade 4Grade 3Grade 4Grade 3Grade 4Grade 3Grade 4
Anemia200000114
Neutropenia2021003110
Febrile neutropenia000020103
Hypoalbuminemia000000101
Hypocalcemia000000101
Hypokalemia000000101
Hypophosphatemia000000101
Hypotension000000101
Leukopenia102000317
Worsening anemia000000101
DHP107 dose levelTotal
150 mg/m2 b.i.d. (n = 3)200 mg/m2 b.i.d. (n = 6)225 mg/m2 b.i.d. (n = 4)250 mg/m2 b.i.d. (n = 4)
Adverse eventsGrade 3Grade 4Grade 3Grade 4Grade 3Grade 4Grade 3Grade 4
Anemia200000114
Neutropenia2021003110
Febrile neutropenia000020103
Hypoalbuminemia000000101
Hypocalcemia000000101
Hypokalemia000000101
Hypophosphatemia000000101
Hypotension000000101
Leukopenia102000317
Worsening anemia000000101

Dose‐limiting toxicity.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close